Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Abbott Laboratories (ABT) News - StockMarketCap

Stocks›Abbott Laboratories☆

● At closeAs of Jul 2, 2026

Abbott Laboratories

ABT✓

HealthcareMedical - DevicesNYSE

$95.39+3.48%

$166.15BMarket cap

25.19xP/E ratio

8.81MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$95.39

$3.21 (+3.48%) · 24h

Key metrics

Market cap$166.15B+3.37%

Enterprise value$185.19B

Volume (24h)8.81M

P/E ratio (TTM)25.19x

P/S ratio (TTM)3.50x

Dividend yield2.69%

Shares outstanding1.74B

Trading range

Previous close$92.18

Day range$91.91 - $95.74

52-week range$81.97 - $137.49

Abbott Laboratories (ABT) operates in the Medical - Devices industry within the Healthcare sector, listed on NYSE.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news